Intramembrane receptor–receptor interactions: a novel principle in molecular medicine
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Summary.In 1980/81 Agnati and Fuxe introduced the concept of intramembrane receptor–receptor interactions and presented the first experimental observations for their existence in crude membrane preparations. The second step was their introduction of the receptor mosaic hypothesis of the engram in 1982. The third step was their proposal that the existence of intramembrane receptor–receptor interactions made possible the integration of synaptic (WT) and extrasynaptic (VT) signals. With the discovery of the intramembrane receptor–receptor interactions with the likely formation of receptor aggregates of multiple receptors, so called receptor mosaics, the entire decoding process becomes a branched process already at the receptor level in the surface membrane. Recent developments indicate the relevance of cooperativity in intramembrane receptor–receptor interactions namely the presence of regulated cooperativity via receptor–receptor interactions in receptor mosaics (RM) built up of the same type of receptor (homo-oligomers) or of subtypes of the same receptor (RM type1). The receptor–receptor interactions will to a large extent determine the various conformational states of the receptors and their operation will be dependent on the receptor composition (stoichiometry), the spatial organization (topography) and order of receptor activation in the RM. The biochemical and functional integrative implications of the receptor–receptor interactions are outlined and long-lived heteromeric receptor complexes with frozen RM in various nerve cell systems may play an essential role in learning, memory and retrieval processes. Intramembrane receptor–receptor interactions in the brain have given rise to novel strategies for treatment of Parkinson’s disease (A2A and mGluR5 receptor antagonists), schizophrenia (A2A and mGluR5 agonists) and depression (galanin receptor antagonists). The A2A/D2, A2A/D3 and A2A/mGluR5 heteromers and heteromeric complexes with their possible participation in different types of RM are described in detail, especially in the cortico-striatal glutamate synapse and its extrasynaptic components, together with a postulated existence of A2A/D4 heteromers. Finally, the impact of intramembrane receptor–receptor interactions in molecular medicine is discussed outside the brain with focus on the endocrine, the cardiovascular and the immune systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Origins of Order: Self-Organization and Selection in Evolution
Kauffman, S. A. (1993) · doi:10.1093/oso/9780195079517.001.0001 · Cited by 7,855
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 2×
“…noted that the receptor activity-modifying proteins (RAMP) regulate the pharmacology of the receptors for the calcitonin family of peptide hormones (McLatchie et al., 1998; see also Foord et al., 2005) like calcitonin gene-related peptide (CGRP), adrenomedullin (ADM) and intermedin (Roh et al.,…”
Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens
Nicola, S. M., Surmeier, D. J., & Malenka, R. C. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.185 · Cited by 931
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
Meyer-Lindenberg, A., Miletich, R. S., Kohn, P. D., Esposito, G., Carson, R. E., Quarantelli, M., Weinberger, D. R., & Berman, K. F. (2002) · Nature Neuroscience · doi:10.1038/nn804 · Cited by 652 · cited 2×
“schizophrenia (Meyer-Lindenberg et al., 2002).”
Half a century of antipsychotics and still a central role for dopamine D2 receptors
Kapur, S., & Mamo, D. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.004 · Cited by 638 · cited 1×
“Development of A2A agonists for treatment of schizophrenia based on the intramembrane A2A=D2 receptor interaction in the ventral striato-pallidal GABA pathway Blockade of D2 receptors still plays a key role in mediating the antipsychotic actions of neuroleptic drugs (Kapur and Mamo, 2003).”
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
Goldman-Rakic, P., Castner, S., Svensson, T., Siever, L., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1793-y · Cited by 544 · cited 1×
“In this process reduced NMDA mediated glutamate transmission seems to play a major role and the resulting reduction of neocortical D1 mediated transmission may contribute to the deficits in cognition and to the negative symptoms of schizophrenia (see Goldman-Rakic et al., 2004).”
Lee, F. J. S., Xue, S., Pei, L., Vukusic, B., Chéry, N., Wang, Y., Wang, Y. T., Niznik, H. B., Yu, X.-M., & Liu, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00962-5 · Cited by 542 · cited 1×
“Defined-function mutants have been used to give access to receptor–receptor interactions in LH receptors (Lee et al., 2002).”
Roh, J., Chang, C. L., Bhalla, A., Klein, C., & Hsu, S. Y. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305332200 · Cited by 443 · cited 1×
“…that the receptor activity-modifying proteins (RAMP) regulate the pharmacology of the receptors for the calcitonin family of peptide hormones (McLatchie et al., 1998; see also Foord et al., 2005) like calcitonin gene-related peptide (CGRP), adrenomedullin (ADM) and intermedin (Roh et al., 2004).”
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
Hedlund, P. B., Huitron-Resendiz, S., Henriksen, S. J., & Sutcliffe, J. G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.012 · Cited by 281 · cited 2×
“…€Ogren et al., 1979; Peroutka and Snyder, 1979) and that inhibition of 5-HT7 receptors and their inactivation produces antidepressant-like behaviour (Hedlund et al., 2005) the 5-HT hypothesis of depression should be modified to state that depression may be induced when a unbalance in the…”
Cited by
Purinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illes, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 397
de la Mora, M. P., Gallegos-Cari, A., Arizmendi-García, Y., Marcellino, D., & Fuxe, K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.010 · Cited by 296
Self-citationUnderstanding wiring and volume transmission
Agnati, L. F., Guidolin, D., Guescini, M., Genedani, S., & Fuxe, K. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.03.003 · Cited by 287
Self-citationConformational cross-talk between α2A-adrenergic and μ-opioid receptors controls cell signaling
Vilardaga, J.-P., Nikolaev, V. O., Lorenz, K., Ferrandon, S., Zhuang, Z., & Lohse, M. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.64 · Cited by 264
Fuxe, K., Marcellino, D., Borroto-Escuela, D. O., Frankowska, M., Ferraro, L., Guidolin, D., Ciruela, F., & Agnati, L. F. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2010.506191 · Cited by 74
“Novel strategies for drug treatment have been introduced based on targeting the heterodimers and receptor mosaics and the use of combined treatments in view of the likely existence of disease and tissue specific heteromers (40,56,57,62,63).”
BackgroundSelf-citation
Metadata
- Authors
- Fuxe, K., Canals, M., Torvinen, M., Marcellino, D., Terasmaa, A., Genedani, S., Leo, G., Guidolin, D., Diaz-Cabiale, Z., Rivera, A., Lundstrom, L., Langel, U., Narvaez, J., Tanganelli, S., Lluis, C., Ferré, S., Woods, A., Franco, R., & Agnati, L. F.
- Venue
- Journal of Neural Transmission
- Published
- 2006-10-27
- Volume
- 114
- Issue
- 1
- Pages
- 49-75
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2047423233
- Cited by
- 118
- References
- 9
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intramembrane receptor–receptor interactions: a novel principle in molecular medicine. https://app.cochat.ai/papers/10.1007/s00702-006-0589-0
- The paper
- Fuxe, K., Canals, M., Torvinen, M., Marcellino, D., Terasmaa, A., Genedani, S., Leo, G., Guidolin, D., Diaz-Cabiale, Z., Rivera, A., Lundstrom, L., Langel, U., Narvaez, J., Tanganelli, S., Lluis, C., Ferré, S., Woods, A., Franco, R., & Agnati, L. F. (2007). Intramembrane receptor–receptor interactions: a novel principle in molecular medicine. Journal of Neural Transmission. https://doi.org/10.1007/s00702-006-0589-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.